The Gross Margin of Bafna Pharmaceuticals Ltd (BAFNAPH.NS) is 32.60%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 32.60% |
| 2023-03-31 | 33.66% |
| 2022-03-31 | 39.76% |
| 2021-03-31 | 36.17% |
| 2020-03-31 | 36.38% |
| 2019-03-31 | 20.77% |
| 2018-03-31 | 6.95% |
| 2017-03-31 | 11.07% |
| 2016-03-31 | 14.53% |
| 2015-03-31 | 6.15% |